Results 221 to 230 of about 54,406 (266)
Some of the next articles are maybe not open access.
Seminars in Cancer Biology, 1999
Genital human papillomavirus (HPV) infections are the viral sexually transmitted diseases most frequently diagnosed that include anogenital condylomas and squamous intra-$bepithelial lesions, among which the precursors of invasive carcinomas of the uterine cervix.
F, Breitburd, P, Coursaget
openaire +2 more sources
Genital human papillomavirus (HPV) infections are the viral sexually transmitted diseases most frequently diagnosed that include anogenital condylomas and squamous intra-$bepithelial lesions, among which the precursors of invasive carcinomas of the uterine cervix.
F, Breitburd, P, Coursaget
openaire +2 more sources
Dermatologic Therapy, 2009
Cervical and other cancers linked to the human papillomavirus (HPV) are a cause of significant morbidity and mortality. Since the discovery of HPV as a cause of these cancers, there has been much research and development in the field of HPV vaccination.
Anita, Satyaprakash +3 more
openaire +2 more sources
Cervical and other cancers linked to the human papillomavirus (HPV) are a cause of significant morbidity and mortality. Since the discovery of HPV as a cause of these cancers, there has been much research and development in the field of HPV vaccination.
Anita, Satyaprakash +3 more
openaire +2 more sources
Vaccination Against Human Papillomavirus
JAMA Dermatology, 2020Who should receive human papillomavirus (HPV) vaccination?Catch-up vaccination is now recommended for all persons through age 26 years. For persons aged 27 through 45 years, clinicians and patients should now jointly decide whether HPV vaccination is appropriate. Routine HPV vaccination at age 11 or 12 years (or as early as age 9 years) continues to be
Dustin H, Marks, Kenneth A, Katz
openaire +2 more sources
Human papillomavirus vaccine update
Current Infectious Disease Reports, 2007With the approval of Gardasil (Merck and Co., Inc., Whitehouse Station, NJ) in June of 2006 and the pending approval of Cervarix (GlaxoSmithKline, London, UK), two prophylactic human papillomavirus (HPV) vaccines will be available for clinical use. Randomized controlled trials have shown that both vaccines are safe and highly effective in preventing ...
Alisa, Ames, Patti, Gravitt
openaire +2 more sources
Human Papillomavirus Vaccine Update
Pediatric Clinics of North America, 2017Rates of cancers attributable to human papillomavirus (HPV) are rising. A safe and extremely effective vaccine is available to prevent many of these cancers. Studies have shown that health care providers' recommendation to immunize is the most important factor in parents' decision.
Blake, Diane R., Middleman, Amy B.
openaire +3 more sources
Human Papillomavirus Vaccination
New England Journal of Medicine, 2023Lauri E, Markowitz, Elizabeth R, Unger
openaire +2 more sources
Human Papillomavirus Vaccine Update
Primary Care: Clinics in Office Practice, 2015This article provides an overview of human papillomavirus (HPV) infection and the burden of HPV-related diseases, including cervical cancer, in the United States. The article presents an overview of HPV vaccination, including the efficacy and safety of the HPV vaccine, recommendations for vaccination in the adolescent population, as well as points to ...
openaire +2 more sources
Vaccines against human papillomavirus
Frontiers in Bioscience, 2007Human papillomavirus has been identified as an etiological factor for cervical cancer, anogenital cancers and a subset of head and neck cancers. These important observations suggest that HPV vaccines have potential in the prevention and treatment of cervical cancer and other HPV-associated malignancies. The HPV genome encodes two HPV late genes, L1 and
Yen-Yu, Lin +4 more
openaire +2 more sources
Vaccination anti-papillomavirus humains
Therapies, 2005Les papillomavirus humains sont des virus a tropisme epithelial, responsables pour ceux d'entre eux qui sont oncogenes du cancer du col de l'uterus. Cette revue de la litterature aborde les vaccins en developpement, qu'ils soient prophylactiques ou therapeutiques.
openaire +1 more source
Emerging human papillomavirus vaccines
Expert Opinion on Emerging Drugs, 2005Human papillomavirus (HPV) infections are a leading cause of virus-associated cancers of the anogenital, oropharyneal and cutaneous epithelium. The most prevalent of these is cervical cancer, which is responsible for approximately 500,000 deaths annually worldwide.
openaire +2 more sources